Personal statement

Marion is a qualified pharmacist who graduated from The Robert Gordon's University with a BSc in Pharmacy followed by a MSc in Clinical Pharmacy at the Universtiy of Strathclyde. She obtained an Advanced Diploma in Clinical Pharmacy Teaching from the University of Leeds.

She holds a senior joint appointment with the NHS in Scotland as Chief Pharmacist, Public Health and intelligence, National Services Scotland which provides national and specialist services across Scotland. In 2008 Marion took up a 50% appointment as Professor of Pharmacy Practice in SIPBS.

Publications

Costs in the treatment of schizophrenia in adults receiving atypical antipsychotics : an eleven-year cohort in Brazil: Barbosa Wallace Breno, de Oliveira Costa Juliana, Lovato Pires de Lemos Livia, Gomes Rosângela Maria, de Oliveira Helian Nunes, Ruas Cristina Mariano, de Assis Acurcio Francisco, Barbui Corrado, Bennie Marion, Godman Brian, Guerra Júnior Augusto Afonso; Applied Health Economics and Health Policy Vol 16, pp. 697-709, (2018); http://dx.doi.org/10.1007/s40258-018-0408-4
Evaluating statin utilisation in clinical practice in Scotland : impact of statin intensity on adherence and persistence to therapy: Mueller Tanja, do Nascimento Renata Cristina R. Macedo, Bennie Marion, Godman Brian, Hurding Simon, MacBride Stewart Sean, Guerra Júnior Augusto Afonso, de Assis Acurcio Francisco, Morton Alec, Kurdi Amanj; 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, (2018); http://dx.doi.org/10.1002/pds.4629
Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish National Health System : influence and implications: Leporowski Axel, Godman Brian, Kurdi Amanj, MacBride-Stewart Sean, Ryan Margaret , Hurding Simon, do Nascimento Renata CRM, Bennie Marion, Morton Alec; Expert Review of Pharmacoeconomics and Outcomes Research, (2018); http://dx.doi.org/10.1080/14737167.2018.1501558
The long-term costs for treating Multiple Sclerosis in a 16-year retrospective cohort study in Brazil: Diniz Isabela Maia, Guerra Júnior Augusto Afonso, Lovato Pires de Lemos Livia, Souza Kathiaja M, Godman Brian, Bennie Marion, Wettermark Björn , de Assis Acurcio Francisco, Alvares Juliana, Gurgel Andrade Eli Iola, Cherchiglia Mariangela Leal, de Araújo Vânia Eloisa; PLoS ONE, (2018); http://dx.doi.org/10.1371/journal.pone.0199446
Using existing NHS datasets to determine outcomes of cancer medicines : a feasibility study: Baillie Kelly, Mueller Tanja, Pan Jiafeng, Crearie Christine, Laskey Jennifer, Jones Robert, Bennie Marion; 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, (2018)
Optimising carbapenem use through a national quality improvement programme: Robson Siân E, Cockburn Alison, Sneddon Jacqueline, Mohana Abdulrhman, Bennie Marion, Mullen Alexander B., Malcolm William, Armstrong Jennifer, Patton Andrea, Seaton Ronald Andrew; Journal of Antimicrobial Chemotherapy, (2018); http://dx.doi.org/10.1093/jac/dky171

more publications

Research interests

Marion's research portfolio is focused on development of a robust evidence base to support the safe, effective and person centred care through use of medicines and other health technologies. Key areas of interest:

Pharmacoepidemiology
Pharmacy Practice
Healthcare Interventions

Projects

Human Factors Work Programme: Bennie, Marion (Principal Investigator); Period 01-Apr-2018 - 31-Mar-2019
EMA Diclofenic Study: Bennie, Marion (Principal Investigator); Period 01-Oct-2017 - 01-Apr-2019
EMA - Impact of EU labels changes for hydroxyzine products: Bennie, Marion (Principal Investigator); Period 01-Feb-2018 - 31-Jul-2019
Effectiveness and Pharmacoepidemiology Studies - Framework Agreement: Bennie, Marion (Principal Investigator) Kavanagh, Kimberley (Co-investigator) Robertson, Charles (Co-investigator); Period 05-Oct-2015 - 04-Oct-2019
Rutherford Fund Fellowship at HDR UK: Risk Prediction in Pharmacoepidemiology: Bennie, Marion (Co-investigator) Robertson, Charles (Co-investigator) Carragher, Raymond Bernard (Fellow); Period 14-Feb-2018 - 13-Feb-2021
Fast-tracking Health Innovation for NHS Scotland (MRC Confidence in Concept 2017) / R170262-104: Kavanagh, Kimberley (Principal Investigator) Bennie, Marion (Co-investigator) Lennon, Marilyn (Co-investigator) Maguire, Roma (Co-investigator) Robertson, Charles (Co-investigator); Period 01-Mar-2017 - 28-Feb-2019

more projects

Address

Strathclyde Institute of Pharmacy and Biomedical Sciences
John Arbuthnott Building Robertson Wing

Location Map

View University of Strathclyde in a larger map

University of Strathclyde

My Saved Pages

My Saved Courses

Recently visited

Professor Marion Bennie

Strathclyde Institute of Pharmacy and Biomedical Sciences